Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Tumor Hypoxia: Causative Factors, Compensatory Mechanisms, and Cellular Response

Open access
Vaupel, Peter, Harrison, Louis · 2004 · The Oncologist

Abstract

Learning Objectives: After completing this course, the reader will be able to: Explain the effect of hypoxia on resistance to treatment. Describe the causes of tumor hypoxia. Characterize cellular response to hypoxia. Access and take the CME test online and receive 1 hour of AMA PRA category 1 credit at CME.TheOncologist.com Hypoxia is a characteristic feature of locally advanced solid tumors resulting from an imbalance between oxygen (O2) supply and consumption. Major causative factors of tumor hypoxia are abnormal structure and function of the microvessels supplying the tumor, increased diffusion distances between the nutritive blood vessels and the tumor cells, and reduced O2 transport capacity of the blood due to the presence of disease- or treatment-related anemia. Tumor hypoxia is a therapeutic concern since it can reduce the effectiveness of radiotherapy, some O2-dependent cytotoxic agents, and photodynamic therapy. Tumor hypoxia can also negatively impact therapeutic outcome by inducing changes in the proteome and genome of neoplastic cells that further survival and malignant progression by enabling the cells to overcome nutritive deprivation or to escape their hostile environment. The selection and clonal expansion of these favorably altered cells further aggravate tumor hypoxia and support a vicious circle of increasing hypoxia and malignant progression while concurrently promoting the development of more treatment-resistant disease. This pattern of malignant progression, coupled with the demonstration of a relationship between falling hemoglobin level and worsening tumor oxygenation, highlights the need for effective treatment of anemia as one approach for correcting anemic hypoxia in tumors, and in so doing, possibly improving therapeutic response.

Overview

Integrity signals

Registry

Crossref · 10.1634/theoncologist.9-90005-4

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Research works printed but not linked: 2

  1. Schwarz, 1909, Über Desensibilisierung gegen Röntgen- und Radiumstrahlen, Münchener Med Wochenschr, 24, 1
  2. Zander, 1996, [Oxygen supply and acid-base status in extreme anemia.] Anaesthesiol Intensivmed Notfallmed Schmerzther, 31, 492

Cited by

See all 761

Metadata

Authors
Vaupel, P., & Harrison, L.
Affiliations
  • Johannes Gutenberg University Mainz (DE)
  • Mount Sinai Beth Israel (US)
Corresponding author
Vaupel, Peter
Venue
The Oncologist
Published
2004-11-01
Volume
9
Issue
S5
Pages
4-9
ISSN
  • 1083-7159 (ISSN-L)
  • 1549-490X
OpenAlex
W2123894943
Cited by
761
References
28
Citations by year
2026: 13 · 2025: 20 · 2024: 34 · 2023: 45 · 2022: 34 · 2021: 50 · 2020: 59 · 2019: 43 · 2018: 38 · 2017: 46 · 2016: 42 · 2015: 44 · 2014: 38 · 2013: 31 · 2012: 40
FWCI
7.11
Type
journal article
Language
en
Open access
Locations
  • The Oncologist (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
tumor hypoxia, tumor microvasculature, anemia, anemic hypoxia, treatment resistance, radiotherapy resistance, photodynamic therapy, hypoxia response, malignant progression, tumor oxygenation, hemoglobin, clonal expansion
MeSH terms
Adaptation, Physiological, Anemia, Cell Survival, Cell Transformation, Neoplastic, Humans, Neoplasms, Neovascularization, Pathologic, Oxygen, Cell Hypoxia, Disease Progression, Drug Resistance, Neoplasm

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor Hypoxia: Causative Factors, Compensatory Mechanisms, and Cellular Response. https://app.cochat.ai/papers/10.1634/theoncologist.9-90005-4
The paper
Vaupel, P., & Harrison, L. (2004). Tumor Hypoxia: Causative Factors, Compensatory Mechanisms, and Cellular Response. The Oncologist. https://doi.org/10.1634/theoncologist.9-90005-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.